Therefore we hypothesized that ZNF322A in lung cancer may contribute to lung cancer stem cell-like (CSC-like) reprogramming through transcriptionally regulating stemness transcription factors, such as Oct4, Nanog, Sox2 and c-Myc. The gene discussed is MYC; the disease is lung carcinoma.